Baseline renal functions predict the effect of canakinumab on regression of proteinuria in patients with familial Mediterranean fever

Yildirim, Tolga; Yilmaz, Rahmi; Saglam, Arzu; Uzerk-Kibar, Muge; Jabrayilov, Jabrayil; Erdem, Yunus.
Nefrología (Madrid) ; 41(6): 632-639, nov.-dic. 2021. ilus, graf, tab
Artículo en Inglés | IBECS (España) | ID: ibc-227950

Documentos relacionados

  1. Baseline renal functions predict the effect of canakinumab on regression of proteinuria in patients with familial Mediterranean fever.
  2. Efficacy and safety of anti-interleukin-1 in children with colchicine-resistant familial Mediterranean fever.
  3. Pediatric Recurrent Pericarditis: Appropriateness of the Standard of Care and Response to IL-1 Blockade.
  4. Factors affecting patient-acceptable symptom states and treatment decision in familial Mediterranean fever.
  5. A mathematical model of immunomodulatory treatment in myocardial infarction.
  6. Autoimmune Neuroinflammatory Diseases: Role of Interleukins.
  7. Current treatment options for monogenic periodic fever syndromes - the role of interleukin 1 inhibitors.
  8. Colchicine-intolerant familial mediterranean fever patients: A comparative study between different colchicine doses and IL-1 inhibitor monotherapy.
  9. Mast Cell Cytokines IL-1, IL-33, and IL-36 Mediate Skin Inflammation in Psoriasis: A Novel Therapeutic Approach with the Anti-Inflammatory Cytokines IL-37, IL-38, and IL-1Ra.
  10. INDICATORS OF ENDOTHELIAL DYSFUNCTION, MARKERS OF INFLAMMATION AND LIPID METABOLISM IN PATIENTS WITH HYPERTENSION WITH THE ADMINISTRATION OF QUERCETIN.